European Journal of Medicinal Chemistry Reports

Elsevier

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

European Journal of Medicinal Chemistry Reports is an open-access journal published by Elsevier in France, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,400 USD. Declared review time at DOAJ: 11 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
2772-4174
Country
France
Languages
english
Access
Open access
Declared publication charge
2,400 USD
Articles in DOAJ
338
Declared review time
11 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2021-11-30
Indexing
DOAJ
APC
2,400 USD
Declared review time (DOAJ)
11 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

338

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

11weeks

Works in OpenAlex

343

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

25

i10-index

98

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2026-04-27
Added to DOAJ
2021-11-30
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
98%
ORCID iDs in current deposits
86%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
EJMECH reports
Source type
journal
NLM unique ID (PubMed)
9918451287006676
Classification4

Subjects (DOAJ)

Medicine: Pharmacy and materia medicaMedicine: Other systems of medicine

LCC codes

RS1-441RZ201-999

Subject areas

  • Synthesis and biological activity
  • Synthesis and biological activity
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Click Chemistry and Applications
  • Click Chemistry and Applications
  • Cholinesterase and Neurodegenerative Diseases
  • Cholinesterase and Neurodegenerative Diseases
Show all subjects (50)
  • Synthesis and Biological Evaluation
  • Synthesis and Biological Evaluation
  • Cancer therapeutics and mechanisms
  • Natural product bioactivities and synthesis
  • Natural product bioactivities and synthesis
  • Cancer therapeutics and mechanisms
  • Multicomponent Synthesis of Heterocycles
  • Multicomponent Synthesis of Heterocycles
  • Synthesis and Characterization of Heterocyclic Compounds
  • Synthesis and bioactivity of alkaloids
  • Synthesis and Characterization of Heterocyclic Compounds
  • Synthesis and bioactivity of alkaloids
  • Peptidase Inhibition and Analysis
  • Nanoparticle-Based Drug Delivery
  • Chemical Synthesis and Analysis
  • Nanoparticle-Based Drug Delivery
  • Chemical Synthesis and Analysis
  • Bioactive Compounds and Antitumor Agents
  • Marine Sponges and Natural Products
  • Peptidase Inhibition and Analysis
  • Alzheimer's disease research and treatments
  • Synthesis of Organic Compounds
  • Bioactive Compounds and Antitumor Agents
  • Marine Sponges and Natural Products
  • Alzheimer's disease research and treatments
  • Synthesis of Organic Compounds
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Enzyme function and inhibition
  • Carbohydrate Chemistry and Synthesis
  • Carbohydrate Chemistry and Synthesis
  • Protein Degradation and Inhibitors
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Enzyme function and inhibition
  • Protein Degradation and Inhibitors
  • Antibiotic Resistance in Bacteria
  • RNA Interference and Gene Delivery
  • Microbial Natural Products and Biosynthesis
  • Microbial Natural Products and Biosynthesis
  • Tuberculosis Research and Epidemiology
  • Tuberculosis Research and Epidemiology
  • Antibiotic Resistance in Bacteria
  • RNA Interference and Gene Delivery

Keywords (DOAJ)

  • biologically active compounds
  • medicinal chemistry
  • drug-receptor interactions
  • natural products
  • traditional chinese medicine

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: